Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
Abstract Background Studies from Asia indicate that normothermic intraperitoneal chemotherapy (NIPEC) may confer survival benefit in patients with gastric peritoneal carcinomatosis (PC). However, data regarding this approach is lacking in western population. The current STOPGAP trial is intended to...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2023-03-01
|
| Серии: | BMC Cancer |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12885-023-10680-1 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|